This is one of the biggest prescribed generic drugs out there as it was just last year that both Teva and Ranbaxy both announced the immediate sale of their generic Lipitor formulas once the patent expire. Almost 1 million generic prescriptions are written a week for one of the formulas, and that’s a lot of scripts so the lion’s share goes between both companies. The drug is manufactured here in the US at a New Jersey plant. Atorvastatin calcium is the generic name for the drug. BD
Ranbaxy is pulling the pills from the U.S. because they may contain small particles of glass, the company said in a statement on its website. The recall of atorvastatin will cause a “temporary disruption” in the supply of the drug and it will take two weeks to complete an investigation into the issue, Ranbaxy said.
Ranbaxy, which was cleared by U.S. regulators to sell copies of the cholesterol pill last year, agreed to make changes at its manufacturing plants to settle allegations that its pharmaceuticals didn’t meet FDA standards, according to a proposed settlement filed by the Justice Department in January. The company announced on Dec. 21 that it had reached an agreement with the FDA and committed to tightening procedures and policies to comply with industry standards.